ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

GLUE Monte Rosa Therapeutics Inc

5.79
0.19 (3.39%)
최종 업데이트: 02:20:12
15분 지연
기업명 주식 심볼 시장 주식 타입
Monte Rosa Therapeutics Inc GLUE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.19 3.39% 5.79 02:20:12
개장가 저가 고가 종가 전일 종가
5.82 5.645 5.85 5.60
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:01GLOBEMonte Rosa Therapeutics Announces the Departure of Owen..
14/03/202420:00GLOBEMonte Rosa Therapeutics Announces Fourth Quarter and Full..
11/03/202420:00GLOBEMonte Rosa Therapeutics Announces Initiation of IND Enabling..
31/01/202421:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
08/01/202421:47EDGAR2Form 8-K - Current report
08/01/202421:15GLOBEMonte Rosa Therapeutics Provides Corporate Update and Key..
05/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202421:00GLOBEMonte Rosa Therapeutics to Present at the 42nd Annual J.P...
21/11/202321:00GLOBEMonte Rosa Therapeutics to Present at Piper Sandler..
09/11/202321:27EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEMonte Rosa Therapeutics Announces Third Quarter 2023..
08/11/202300:00GLOBEMonte Rosa Therapeutics Presents Preclinical Data at ACR..
27/10/202320:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
27/10/202306:01EDGAR2Form 8-K - Current report
27/10/202305:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/10/202305:30GLOBEMonte Rosa Therapeutics Announces $25 Million Registered..
17/10/202320:55EDGAR2Form 8-K - Current report
17/10/202320:00GLOBEMonte Rosa Therapeutics Announces Interim PK/PD and Clinical..
19/08/202305:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/08/202306:16EDGAR2Form 144 - Report of proposed sale of securities
10/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:19EDGAR2Form 8-K - Current report
10/08/202320:15GLOBEMonte Rosa Therapeutics Announces Second Quarter 2023..
26/07/202320:53EDGAR2Form 8-K - Current report
26/07/202320:30GLOBEMonte Rosa Therapeutics Appoints Dr. Anthony M. Manning to..
31/05/202305:30GLOBEMonte Rosa Therapeutics to Present at Upcoming Investor and..
23/05/202320:30GLOBEMonte Rosa Therapeutics Advances Second Development..
11/05/202320:30GLOBEMonte Rosa Therapeutics Announces First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock